Last updated: March 19, 2024
Sponsor: Northwestern University
Overall Status: Completed
Phase
N/A
Condition
Benign Prostatic Hyperplasia (Enlarged Prostate)
Prostate Disorders
Treatment
Richard Wolf 24F Laser scope
Karl Storz 28F Laser Scope
Clinical Study ID
NCT05308017
STU00215646
Ages 18-89 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients Males 18-89 undergoing HoLEP for the treatment of bothersome lower urinarytract symptoms
Exclusion
Exclusion Criteria:
- Patients who lack decisional capacity
Study Design
Total Participants: 152
Treatment Group(s): 2
Primary Treatment: Richard Wolf 24F Laser scope
Phase:
Study Start date:
May 01, 2022
Estimated Completion Date:
September 29, 2023
Connect with a study center
Northwestern University
Chicago, Illinois 60611
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.